Related Experiment Video
Updated: Jul 20, 2026
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Diabetic atherosclerosis mouse models
1Department of Cardiovascular Disease, Merck Research Laboratories, RY 80W-250, 126 East Lincoln Avenue, Rahway, NJ 07065, USA. ken_wu@merck.com
Insights
Diabetic atherosclerosis mouse models are crucial for research, but no single model perfectly replicates human disease. This review evaluates existing models to guide selection for studying diabetes-accelerated atherosclerosis and testing therapies.
Area of Science:
- Cardiovascular Research
- Metabolic Disease Research
- Animal Models in Atherosclerosis
Background:
- Coronary heart disease (CHD) from atherosclerosis is a leading cause of death, particularly accelerated in diabetic patients.
- Understanding diabetes-accelerated atherosclerosis is critical for developing effective treatments.
- Mice are the primary animal model for studying diabetic atherosclerosis due to their advantages.
Purpose of the Study:
- To review and characterize common diabetic atherosclerosis mouse models.
- To assess how well these models mimic human diabetic atherosclerosis.
- To guide the selection of appropriate models for research and therapeutic evaluation.
Main Methods:
- Review of existing literature on diabetic atherosclerosis mouse models.
- Analysis of models based on retention of diabetic condition.
- Evaluation of models regarding acceleration of atherosclerosis and atherogenic inflammation.
- Assessment of model response to medical interventions.
Main Results:
- Several diabetic atherosclerosis mouse models have been developed.
- No single model perfectly recapitulates human diabetic atherosclerosis.
- Models vary in their ability to maintain diabetes, accelerate atherosclerosis, and respond to treatments.
Conclusions:
- Careful selection of diabetic atherosclerosis mouse models is essential for accurate research.
- Understanding model-specific characteristics aids in studying disease mechanisms and evaluating therapies.
- Further refinement of models is needed to better approximate human diabetic atherosclerosis.
Abstract:
Coronary heart disease (CHD) due to atherosclerosis is the leading cause of death in the USA, and accelerated CHD has emerged as a leading cause of morbidity and mortality in diabetic patients in the USA and worldwide. This has highlighted the importance and urgency of studying the mechanism of diabetic atherosclerosis and exploring therapeutic options. Due to its unique advantages over other animal models, the mouse is the most used model for studying the mechanism of diabetes-accelerated atherosclerosis and exploring effective therapeutic approaches. In the past decade, several diabetic atherosclerosis mouse models have been established. Currently, however, there is no ideal animal model for diabetic atherosclerosis. To determine the characteristics of the models that more closely resemble human diabetic atherosclerosis disease, this review focuses on the common diabetic atherosclerosis mouse models with respect to the following issues: (1) whether the mice retain diabetic condition; (2) whether the diabetes accelerates atherosclerosis or increases atherogenic inflammation; (3) whether these factors respond to medical interventions. The discussion is aimed at identifying different diabetic mouse models and their features, in order to heighten awareness of the appropriate models that may provide useful tools for studying the mechanism of diabetes-accelerated atherosclerosis and evaluating therapeutic options.
